Buried de-epithelialized flap: An original solution to fill dead space after sarcoma resection in the thigh. Surgical technique and results of 12 cases.

De-epithelialized skin flap Skin complications Soft tissue sarcoma

Journal

Orthopaedics & traumatology, surgery & research : OTSR
ISSN: 1877-0568
Titre abrégé: Orthop Traumatol Surg Res
Pays: France
ID NLM: 101494830

Informations de publication

Date de publication:
01 Nov 2023
Historique:
received: 19 06 2022
revised: 25 07 2023
accepted: 28 08 2023
pubmed: 6 11 2023
medline: 6 11 2023
entrez: 3 11 2023
Statut: aheadofprint

Résumé

Soft tissue sarcomas (STS) are often treated with wide excision in combination with adjuvant or neoadjuvant radiotherapy. This is currently the gold standard procedure for the treatment of STS that arise in the extremities. Wound healing complications frequently occur and negatively affect the prognosis. One of the options is to use a buried de-epithelialized flap as it can increase the lymphatic flow, fill the dead space, and cover neurovascular structures and implants. This aim of this retrospective study were two-fold. 1) Describe the surgical technique for this buried de-epithelialized flap after STS removal in the thigh. 2)Evaluate the efficacy of the buried de-epithelialized flap for decreasing wound complications based on a small case series and compare it with previous publications. We hypothesized that the complication rate of this flap is not higher than the published complication rate for traditional flaps. Twelve patients (7 women and 5 men) with a mean age of 62±12years (38-76), who underwent surgical removal of an STS in the thigh with coverage by a buried de-epithelialized flap were reviewed at a mean follow-up of 15.8months (range 8-24). Two patients presented with a postoperative wound infection (17%): one superficial and one deep at the surgical site. Neither required an additional plastic surgery procedure. Another patient had a dislocation of their total hip arthroplasty that was managed by closed reduction. One patient died from metastatic progression. There was no skin necrosis of the superficial skin edges, no hematoma or seroma in the other 10 patients. The flap was still visible on cross-sectional imaging at 1 month postoperative with no fluid between the tissue planes or signs of necrosis. The rate of wound healing complications that required surgical treatment was 17% in our case series, versus 16 to 56% in previous publications reporting the results of suture closure only. A buried de-epithelialized flap reduces the risk of skin complications by filling dead space, improving lymphatic flow and covering critical structures. It is a reliable and reproducible option after wide local excision of STS in the thigh, with no additional morbidity. IV, retrospective study.

Identifiants

pubmed: 37923176
pii: S1877-0568(23)00290-6
doi: 10.1016/j.otsr.2023.103748
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103748

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Auteurs

Ramy Samargandi (R)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia; Service de chirurgie orthopédique, hôpital Trousseau, CHRU de Tours, faculté de médecine, université de Tours, centre Val-de-Loire, Tours, France. Electronic address: ramy.samargandi@hotmail.com.

Rayane Benhenneda (R)

Service de chirurgie orthopédique, hôpital Trousseau, CHRU de Tours, faculté de médecine, université de Tours, centre Val-de-Loire, Tours, France.

Philippe Rosset (P)

Service de chirurgie orthopédique, hôpital Trousseau, CHRU de Tours, faculté de médecine, université de Tours, centre Val-de-Loire, Tours, France.

Audrey Bisson-Patoue (A)

Service de chirurgie plastique, hôpital Trousseau, CHRU de Tours, faculté de médecine, université de Tours, centre Val-de-Loire, Tours, France.

Louis-Romée Le Nail (LR)

Service de chirurgie orthopédique, hôpital Trousseau, CHRU de Tours, faculté de médecine, université de Tours, centre Val-de-Loire, Tours, France; CNRS ERL 7001 LNOX: Leukemic niche & Redox metabolisme, EA 7501 GICC, université de Tours, Tours, France.

Classifications MeSH